Literature DB >> 11813205

Refined mapping of allele loss at chromosome 10q23-26 in prostate cancer.

Barbara Leube1, Matthias Drechsler, Kristina Mühlmann, Reinhold Schäfer, Wolfgang A Schulz, Simon Santourlidis, Aristoteles Anastasiadis, Rolf Ackermann, Tapio Visakorpi, Wolfram Müller, Brigitte Royer-Pokora.   

Abstract

BACKGROUND: Allele loss of at least two segments in 10q, one mapping to the PTEN gene and one more distal were described in prostate cancer, with loss more frequent in advanced prostate cancer.
METHODS: A 63 cM region from 10q23 to q26 was studied for allele loss (LOH) in 59 prostate cancer samples using a dense map of microsatellite markers.
RESULTS: LOH of at least one marker in 10q was observed in 13/59 tumors. LOH increased with grade and stage. Detailed deletion mapping identified three regions of allele loss. The first region mapped to the site of the PTEN gene, the second is defined by loss of one marker, D10S1692, in one tumor, and the third is defined between markers D10S1757 and D10S587, including DMBT, with a subregion of approximately 1.2 Mb mapping between markers D10S209 and D10S1679, lost in one tumor.
CONCLUSIONS: LOH at the PTEN gene is frequent but mutations in the remaining allele were not detected by SSCP-screening. There may be more than two tumor suppressor (TS) genes mapping more distal of PTEN. The site for these putative TS genes can now be mapped with a dense set of precisely localized markers in a larger series of advanced tumors. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813205     DOI: 10.1002/pros.10038

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

Review 1.  Prognostic prostate tissue biomarkers of potential clinical use.

Authors:  Theodorus H Van der Kwast
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

Review 2.  Prostate cancer and Hedgehog signalling pathway.

Authors:  L M Antón Aparicio; R García Campelo; J Cassinello Espinosa; M Valladares Ayerbes; M Reboredo López; S Díaz Prado; G Aparicio Gallego
Journal:  Clin Transl Oncol       Date:  2007-07       Impact factor: 3.405

3.  Chromosome 10 abnormality predicts prognosis of neuroblastoma patients with bone marrow metastasis.

Authors:  Chi-Yi Jiang; Xiao Xu; Bing-Lin Jian; Xue Zhang; Zhi-Xia Yue; Wei Guo; Xiao-Li Ma
Journal:  Ital J Pediatr       Date:  2021-06-09       Impact factor: 2.638

4.  Refined physical map of the human PAX2/HOX11/NFKB2 cancer gene region at 10q24 and relocalization of the HPV6AI1 viral integration site to 14q13.3-q21.1.

Authors:  Sheryl M Gough; Margaret McDonald; Xiao-Ning Chen; Julie R Korenberg; Antonino Neri; Tomas Kahn; Michael R Eccles; Christine M Morris
Journal:  BMC Genomics       Date:  2003-03-03       Impact factor: 3.969

5.  Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomy.

Authors:  Chinyere Ibeawuchi; Hartmut Schmidt; Reinhard Voss; Ulf Titze; Mahmoud Abbas; Joerg Neumann; Elke Eltze; Agnes Marije Hoogland; Guido Jenster; Burkhard Brandt; Axel Semjonow
Journal:  Int J Mol Sci       Date:  2015-02-11       Impact factor: 5.923

6.  C10orf116 Gene Copy Number Loss in Prostate Cancer: Clinicopathological Correlations and Prognostic Significance.

Authors:  Jie Meng; Li-Hui Wang; Chun-Lin Zou; Sheng-Ming Dai; Jian Zhang; Yi Lu
Journal:  Med Sci Monit       Date:  2017-10-30

7.  The Effect of Quercetin Nanosuspension on Prostate Cancer Cell Line LNCaP via Hedgehog Signaling Pathway.

Authors:  Nadia Mousavi; Shahrzad Rahimi; Hanane Emami; Amir Hossein Kazemi; Rana Mohammad Taghi Kashi; Ronak Heidarian
Journal:  Rep Biochem Mol Biol       Date:  2021-04

8.  Activation of the hedgehog pathway in advanced prostate cancer.

Authors:  Tao Sheng; Chengxin Li; Xiaoli Zhang; Sumin Chi; Nonggao He; Kai Chen; Frank McCormick; Zoran Gatalica; Jingwu Xie
Journal:  Mol Cancer       Date:  2004-10-13       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.